Disease Markers

/ Table of Contents: 2021

Table of Contents

Table of Contents: 2021

Disease Markers -
Special Issue
- Volume 2021
- Article ID 3532716
- Research Article

Expression of ANGPTL4 in Nucleus Pulposus Tissues Is Associated with Intervertebral Disc Degeneration

Fan-jie Liu | Liang-yu Xie | ... | Dan-dan Wang

Disease Markers -
Special Issue
- Volume 2021
- Article ID 3771990
- Research Article

USP1 Promotes GC Metastasis via Stabilizing ID2

Nuoya Li | Lei Wu | ... | Jinlong Yan

Disease Markers -
Special Issue
- Volume 2021
- Article ID 7190301
- Research Article

Identification of SOX6 and SOX12 as Prognostic Biomarkers for Clear Cell Renal Cell Carcinoma: A Retrospective Study Based on TCGA Database

Xiao Lyu | Xi Zhang | ... | Xu-hui Zhang

Disease Markers -
Special Issue
- Volume 2021
- Article ID 2135942
- Research Article

The Role of Conjunctival Microvasculation Combined with Echocardiography in Evaluating Pulmonary Arterial Hypertension in Systemic Lupus Erythematosus

Jiangbiao Xiong | Shujiao Yu | ... | Rui Wu

Disease Markers -
Special Issue
- Volume 2021
- Article ID 3625662
- Research Article

N-Acetylcysteine Slows Down Cardiac Pathological Remodeling by Inhibiting Cardiac Fibroblast Proliferation and Collagen Synthesis

Jin Zhou | Jing Xu | ... | Aijuan Cheng

Disease Markers -
Special Issue
- Volume 2021
- Article ID 2385406
- Research Article

A Novel Ferroptosis-Related Gene Risk Signature for Predicting Prognosis and Immunotherapy Response in Gastric Cancer

Shi-jin Liu | Ya-bing Yang | ... | Jing-hua Pan

Disease Markers -
Special Issue
- Volume 2021
- Article ID 8709298
- Research Article

miR-190-5p Alleviates Myocardial Ischemia-Reperfusion Injury by Targeting PHLPP1

Yangxue Li | Zhibo Li | ... | Guobin Miao

Disease Markers -
Special Issue
- Volume 2021
- Article ID 5089872
- Research Article

RRM2 Improves Cardiomyocyte Proliferation after Myocardial Ischemia Reperfusion Injury through the Hippo-YAP Pathway

Huamin Yu | Haiyan Tang | ... | Jingming Ruan

Disease Markers -
Special Issue
- Volume 2021
- Article ID 4846683
- Research Article

Identification of a Novel Ferroptosis-Related Gene Prediction Model for Clinical Prognosis and Immunotherapy of Colorectal Cancer

Ya-bing Yang | Jia-xin Zhou | ... | Yun-long Pan

Disease Markers -
Special Issue
- Volume 2021
- Article ID 5917506
- Research Article

Comprehensive Analysis of the Immune and Prognostic Implication of MMP14 in Lung Cancer

Chun-long Zheng | Qiang Lu | ... | Gui-zhen Li

Disease Markers -
Special Issue
- Volume 2021
- Article ID 9628521
- Research Article

FOXC2 Alleviates Myocardial Ischemia-Reperfusion Injury in Rats through Regulating Nrf2/HO-1 Signaling Pathway

Rui Wang | Yonggang Wu | Shoutao Jiang

Disease Markers -
Special Issue
Volume 2021
- Article ID 7694239
- Research Article

Upregulated Transcription Factor PITX1 Predicts Poor Prognosis in Kidney Renal Clear Cell Carcinoma-Based Bioinformatic Analysis and Experimental Verification

Yinglang Zhang | Zhe Zhang | ... | Guochang Bao

Disease Markers -
Special Issue
- Volume 2021
- Article ID 5424623
- Research Article

MALAT-1 Expression Correlates with Prognosis in Non-Small-Cell Lung Carcinoma: A Systematic Review and Meta-analysis

Ran Ran | Jian-wei Jin | Wei-ping Zhang

Disease Markers -
Special Issue
Volume 2021
- Article ID 5759927
- Research Article

A Novel Ferroptosis-Related Gene Signature to Predict Prognosis in Patients with Head and Neck Squamous Cell Carcinoma

Li Xu | Ying-ying Li | ... | Zhao-hui Liu

Disease Markers -
Special Issue
- Volume 2021
- Article ID 4495489
- Research Article

Derivation of a Novel CIHI in Patients with Lung Adenocarcinoma for Estimating Tumor Microenvironment and Clinical Prognosis

Liang Zhou | Guangyan Xu | ... | Weimin Li

1|2|3|4|5|6|7|8

Evaluate your manuscript with the free Manuscript Language Checker

Author guidelines

Editorial board

Databases and indexing

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.